Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Anxiolytic Effect of Intranasal Dexmedetomidine for Severely Anxious Patients in Dental Treatments
NCT05500261Not yet recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Sep 2026
- Primary completion
- Jul 2028
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of dexmedetomidine in Dental anxiety (3 arms), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoint: Modified Dental Anxiety Scale at 30 minutes. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Dental anxiety
Beyond the preview
Go deeper on NCT05500261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05500261.